Activating SRC mutation in a subset of advanced human colon cancers. - Wikidata - wikimedia - TriplyDB

Activating SRC mutation in a subset of advanced human colon cancers.

Activating SRC mutation in a subset of advanced human colon cancers.

http://www.wikidata.org/entity/Q34492512

about

Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2 Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor Bcr interferes with beta-catenin-Tcf1 interaction Adhesion signaling by a novel mitotic substrate of src kinases The role of Src in solid tumors Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling The repertoire of protein kinases encoded in the draft version of the human genome: atypical variations and uncommon domain combinations The molecular rationale of Src inhibition in colorectal carcinomas Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases Autophagy in malignant transformation and cancer progression Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK The hunting of the Src Regulation of SRC family kinases in human cancers Proteogenomic characterization of human colon and rectal cancer Lung Cancer: Are we up to the Challenge?A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism.The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival.Novel insight into mutational landscape of head and neck squamous cell carcinoma The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.A novel group IIA phospholipase A2 interacts with v-Src oncoprotein from RSV-transformed hamster cells.Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.C-terminal Src kinase (Csk)-mediated phosphorylation of eukaryotic elongation factor 2 (eEF2) promotes proteolytic cleavage and nuclear translocation of eEF2 Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.

P2860

Q24290329-DD360275-2B67-445B-A3B8-3E7EFC008ACA Q24294568-7218052F-96DC-40A7-AE3A-8B7465B653ED Q24301556-5AE3FD3E-CE86-4AE1-B189-C281AE60D4F9 Q24302316-3A41A0FF-40F2-4834-9A8E-EDD8B5F64561 Q24594187-859ECDD9-7C5F-491E-B499-7523C2265EFE Q24616659-170646DC-9115-4CA5-90C8-F122525AAC2F Q24626852-76CEAD5D-664F-4F7E-8C1B-F328F5A2C8B9 Q24645231-2976AAA1-56AC-4C69-AB44-12246690ADEC Q24645339-BD9F3DCB-2711-451A-94CD-D698878440F0 Q24648834-3E133B68-CFB5-4284-BF04-B1994DC5DF5A Q24796859-77D12E58-351E-45D5-ACE3-24C59A342DC4 Q24798129-64724832-238E-45B6-BA88-11E8632518A3 Q24803062-6B01B844-DF3A-4DB0-A27A-B7F55D2596E8 Q26853018-B4E40729-EAD1-4585-9CD3-CB2A351E1605 Q26866135-EBA2EE6A-F12E-424F-BBF5-CAA66E5CE6B7 Q27000191-F7D143F0-1D94-4521-9028-CD7782256DD8 Q27851586-50D08233-7975-4A73-87AC-7CA072E40CAF Q28077545-B9ED0B37-2EF8-4291-9B0A-444ECDDA2439 Q28138242-818F889F-704E-4ED6-A3D7-FA60AF872844 Q28199081-1340F31B-B953-47E0-894A-FF06FEC3CF44 Q28243770-E71AE2E8-DB57-42FD-B55C-E8D52786CDED Q28244320-8886548D-8DE7-4D84-AAB4-B2F63B672F7B Q28386607-F51AD60B-1BB7-4D8D-887E-7673638540EC Q28471792-6FC7E8FA-0CCC-40BD-89D6-EDF25FE13F04 Q28476695-A3019A99-B2B0-4F49-B215-7FC65E028CC6 Q30009087-8BB0E080-DC75-4B11-A710-041721BEDFC8 Q30160101-A7AD07F9-4BF1-44E4-9ACF-3D138A9CF6B1 Q30163857-02066825-BE31-4B2E-9EAC-59481F84A38F Q30164215-8CC0D9DB-FE2C-4A1E-AFC8-29FDCFFE2208 Q30167844-51A3DABA-9C01-41B4-94E7-19AA64F80F3E Q30168513-E7734D8E-D72F-47F7-9401-7705F4858E12 Q30441193-295DA625-138A-4453-8F71-21580B166961 Q30490003-EFAF4D38-2D64-4F6C-8E9E-D2FA4D43D3C9 Q30683304-F108E856-7772-4547-A8F9-B4834E195B0D Q30887759-3152B879-5BC0-4AD2-89FF-B268B7DC996C Q33430459-A7359DD1-DF61-4867-B15E-DEDF082BBBE9 Q33530940-A60955A1-38CD-45B6-BC1B-C6B3248ED302 Q33556208-E9E5987D-0353-4F58-9B71-537D74236F6A Q33821187-E5A42CA2-C7E1-43DB-BE3E-865CFEAC4ACC Q33889288-138A4DBE-F9A5-4108-A6CB-D988E9262F6D

P2860

Activating SRC mutation in a subset of advanced human colon cancers.

http://www.wikidata.org/entity/Q34492512

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Activating SRC mutation in a subset of advanced human colon cancers.

@ast

Activating SRC mutation in a subset of advanced human colon cancers.

@en

Activating SRC mutation in a subset of advanced human colon cancers.

@nl

type

label

Activating SRC mutation in a subset of advanced human colon cancers.

@ast

Activating SRC mutation in a subset of advanced human colon cancers.

@en

Activating SRC mutation in a subset of advanced human colon cancers.

@nl

prefLabel

Activating SRC mutation in a subset of advanced human colon cancers.

@ast

Activating SRC mutation in a subset of advanced human colon cancers.

@en

Activating SRC mutation in a subset of advanced human colon cancers.

@nl

P1433

Q34492512-6D68C11B-DFA2-4B30-9B92-E59A0B0ABD98

P1476

Q34492512-8F62F686-ADD4-45DC-A125-90BD4CB7870B

P2093

Q34492512-0E4AC9FE-C10F-4A86-9522-E43B8ACB07F1

Q34492512-55B4FBF8-E179-480C-8C67-FF74BD800D76

Q34492512-6D59DB7F-FB8B-4F5D-9C75-3C0BA3F69234

Q34492512-97175536-F15F-48DC-B067-D56DB9D1B264

Q34492512-99A2FF3B-7676-4431-A870-8F86CB4CA4BF

Q34492512-DDB974C7-EF45-4B1A-8DC1-0C742E608122

Q34492512-E1D4FE82-CB21-487F-B798-8C40ED79AFF8

Q34492512-E39ABE9C-49C2-40FF-BDD3-19141AC646D0

Q34492512-F46CEF99-A354-41D9-AEAC-1060789C0122

Q34492512-FE04F3C1-EA70-4233-9869-1F11D5BD102A

P2888

Q34492512-6F1825DE-1E3A-4D6F-9474-E06067F0A657

P304

Q34492512-A0014741-BCE9-4FC3-9C33-38592855AAEB

P31

Q34492512-639B9F15-24D7-41BD-8A0E-CEDE0E842D59

P356

Q34492512-239C21ED-0677-410A-9D2E-298E6E79474F

P407

Q34492512-9794B91E-D7D2-4C0C-A2DB-4E750A6418D1

P433

Q34492512-92D33F7B-69AD-48E2-B426-9D8CC24FA656

P478

Q34492512-668FB7FF-469B-47B7-B282-602F1A0AA29C

P577

Q34492512-DF5218C4-FB23-4A36-A92C-DB6BAC3447E9

P698

Q34492512-395A3268-8D70-4B0C-81D4-6B9F08B489F6

P356

P1433

Nature Genetics

P1476

Activating SRC mutation in a subset of advanced human colon cancers.

@en

P2093

Coppola D

http://www.w3.org/2001/XMLSchema#string

Fujita DJ

http://www.w3.org/2001/XMLSchema#string

Irby RB

http://www.w3.org/2001/XMLSchema#string

Jove R

http://www.w3.org/2001/XMLSchema#string

Kang J

http://www.w3.org/2001/XMLSchema#string

Karl R

http://www.w3.org/2001/XMLSchema#string

Loubeau JM

http://www.w3.org/2001/XMLSchema#string

Mao W

http://www.w3.org/2001/XMLSchema#string

Trudeau W

http://www.w3.org/2001/XMLSchema#string

Yeatman TJ

http://www.w3.org/2001/XMLSchema#string

P2888

P304

187-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/5971

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9988270

http://www.w3.org/2001/XMLSchema#string